Simultaneous occurrence of PAX8-PPARg and RET-PTC3 rearrangements in a follicular variant of papillary thyroid carcinoma

American Journal of Surgical Pathology

Volumn 36, Issue 9, 2012, Pages 1415-1420

  Caria, Paola ^a   Dettori, Tinuccia ^a   Frau, Daniela Virginia ^a   Di Oto, Enrico ^b   Morandi, Luca ^b   Parmeggiani, Alfredo ^c   Tallini, Giovanni ^b   Vanni, Roberta ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c Azienda USL di Bologna   (Italy)

Author keywords

FV PTC; PAX8 PPARg; RET PTC; thyroid tumor

Indexed keywords

DNA; NCOA4 PROTEIN, HUMAN; NUCLEAR RECEPTOR COACTIVATOR; ONCOPROTEIN; PAX8 PPARGAMMA FUSION PROTEIN, HUMAN; PAX8-PPARGAMMA FUSION PROTEIN, HUMAN;

ARTICLE; CASE REPORT; CELL CULTURE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE REARRANGEMENT; GENETICS; HUMAN; MIDDLE AGED; PATHOLOGY; THYROID FOLLICULAR CARCINOMA; THYROID TUMOR; THYROIDECTOMY;

CARCINOMA, PAPILLARY, FOLLICULAR; CELLS, CULTURED; DNA, NEOPLASM; FEMALE; GENE REARRANGEMENT; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MIDDLE AGED; NUCLEAR RECEPTOR COACTIVATORS; ONCOGENE PROTEINS, FUSION; THYROID NEOPLASMS; THYROIDECTOMY;

EID: 84865467518     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e318264bdd6     Document Type: Article

References (26)

1. Nikiforov YE. Molecular diagnostics of thyroid tumors. Arch Pathol Lab Med. 2011;135:569-577.
2. Caria P, Vanni R. Cytogenetic and molecular events in adenoma and well-differentiated thyroid follicular-cell neoplasia. Cancer Genet Cytogenet. 2010;203:21-29.
3. Zhu Z, Gandhi M, Nikiforova MN, et al. Molecular profile and clinical-pathologic features of the follicular variant of papillary thyroid carcinoma. An unusually high prevalence of RAS mutations. Am J Clin Pathol. 2003;120:71-77. (Pubitemid 37046372)
4. Castro P, Rebocho AP, Soares RJ, et al. PAX8-PPARgamma rearrangement is frequently detected in the follicular variant of papillary thyroid carcinoma. J Clin Endocrinol Metab. 2006;91:213-220. (Pubitemid 43069140)
5. Rivera M, Ricarte-Filho J, Knauf J, et al. Molecular genotyping of papillary thyroid carcinoma follicular variant according to its histological subtypes (encapsulated vs infiltrative) reveals distinct BRAF and RAS mutation patterns. Mod Pathol. 2010;23: 1191-1200.
6. Santarpia L, Myers JN, Sherman SI, et al. Genetic alterations in the RAS/RAF/mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt signaling pathways in the follicular variant of papillary thyroid carcinoma. Cancer. 2010;116:2974-2983.
7. Daniels GH. What if many follicular variant papillary thyroid carcinomas are not malignant? A review of follicular variant papillary thyroid carcinoma and a proposal for a new classification. Endocr Pract. 2011;17:768-787.
8. Frau DV, Lai ML, Caria P, et al. Trisomy 17 as a marker for a subset of noninvasive thyroid nodules with focal features of papillary carcinoma: Cytogenetic and molecular analysis of 62 cases and correlation with histologic findings. J Clin Endocr Metab. 2008;93:177-181.
9. Garcia-Rostan G, Zhao H, Camp RL, et al. RAS mutations are associated with aggressive tumor phenotypes and poor prognosis in thyroid cancer. J Clin Oncol. 2003;21:3226-3235. (Pubitemid 46606254)
10. Fusco A, Chiappetta G, Hus P, et al. Assessment of RET/PTC oncogene activation and clonality in thyroid nodules with incomplete morphological evidence of papillary carcinoma: a search for the early precursors of papillary cancer. Am J Pathol. 2002; 160:2157-2167. (Pubitemid 34663407)
11. Unger K, Wienberg J, Riches A, et al. Novel gene rearrangements in transformed breast cells identified by high-resolution breakpoint analysis of chromosomal aberrations. Endocr Relat Cancer. 2010;17:87-98.
12. Albores-Saavedra J, Gould E, Vardaman C, et al. The macrofollicular variant of papillary thyroid carcinoma: a study of 17 cases. Hum Pathol. 1991;22:1195-1205.
13. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A. AJCC. Cancer Staging Manual. 7th ed. NY: Springer; 2010.
14. Lui WO, Zeng L, Rehrmann V, et al. CREB3L2-PPARgamma fusion mutation identifies a thyroid signaling pathway regulated by intramembrane proteolysis. Cancer Res. 2008;68: 7156-7164.
15. Zhu Z, Ciampi R, Nikiforova MN, et al. Prevalence of RET/PTC rearrangements in thyroid papillary carcinomas: effects of the detection methods and genetic heterogeneity. J Clin Endocrinol Metab. 2006;91:3603-3610. (Pubitemid 44402144)
16. Wang YL, Wang JC, Wu Y, et al. Incidentally simultaneous occurrence of RET/PTC, H4-PTEN and BRAF mutation in papillary thyroid carcinoma. Cancer Lett. 2008;263:44-52.
17. Musholt TJ, Schö nefeld S, Schwarz CH, et al. Impact of pathognomonic genetic alterations on the prognosis of papillary thyroid carcinoma. ESES Vienna presentation. Langenbecks Arch Surg. 2010;395:877-883.
18. Henderson YC, Shellenberger TD, Williams MD, et al. High rate of BRAF and RET/PTC dual mutations associated with recurrent papillary thyroid carcinoma. Clin Cancer Res. 2009;15: 485-491.
19. Stanojevic B, Dzodic R, Saenko V, et al. Mutational and clinicopathological analysis of papillary thyroid carcinoma in Serbia. Endocr J. 2011;58:381-393.
20. Chua EL, Wu WM, Tran KT, et al. Prevalence and distribution of ret/ptc 1, 2, and 3 in papillary thyroid carcinoma in New Caledonia and Australia. J Clin Endocrinol Metab. 2000;85: 2733-2739. (Pubitemid 32269143)
21. Wirtschafter A, Schmidt R, Rosen D, et al. Expression of the RET/PTC fusion gene as a marker for papillary carcinoma in Hashimoto's thyroiditis. Laryngoscope. 1997;107:95-100. (Pubitemid 27045201)
22. Costa AM, Herrero A, Fresno MF, et al. BRAF mutation associated with other genetic events identifies a subset of aggressive papillary thyroid carcinoma. Clin Endocrinol. 2008;68: 618-634. (Pubitemid 351388702)
23. Cameselle-Teijeiro J, Pardal F, Eloy C, et al. Follicular thyroid carcinoma with an unusual glomeruloid pattern of growth. Hum Pathol. 2008;39:1540-1547.
24. Sugg SL, Ezzat S, Rosen IB, et al. Distinct multiple RET/PTC gene rearrangements in multifocal papillary thyroid neoplasia. J Clin Endocrinol Metab. 1998;83:4116-4122. (Pubitemid 28513605)
25. Moses W, Weng J, Khanafshar E, et al. Multiple genetic alterations in papillary thyroid cancer are associated with younger age at presentation. J Surg Res. 2010;160:179-183.
26. Rhoden KJ, Unger K, Salvatore G, et al. RET/papillary thyroid cancer rearrangement in nonneoplastic thyrocytes: follicular cells of Hashimoto's thyroiditis share low-level recombination events with a subset of papillary carcinoma. J Clin Endocrinol Metab. 2006;91:2414-2423. (Pubitemid 43855035)